Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > November 2011

« Previous month Next month »

Fire at Aurobindo API plant injures three, operations unaffected

30-Nov-2011 - Aurobindo Pharma says a fire that broke out at its manufacturing plant in India injuring three employees did not disrupt production operations.

Ideal Cures claims film coating tech is twice as quick as others

30-Nov-2011 - Ideal Cures says its new Instacoat E Series film can cut tablet coating times in half and save manufacturers money.

Virus catching filter helps Novo stop batch tests on live animals

30-Nov-2011 - Novo Nordisk has stopped using living animals in batch quality tests after developing a virus filtration tool for factor VII production.

Cargill stresses importance of cost- efficient taste masking in drug manufacturing

30-Nov-2011 - Taste masking plays a vital role in treatment compliance according to Cargill, which has launched a new flavour technology that it claims can make drugs more pleasant to take and...

Hot topic

The future of HPAPIs according to industry insiders

29-Nov-2011 - High potency APIs are becoming a key focus of the pharmaceutical business, with drug makers from all areas racing to establish a foothold in the market.

USPTO rejects MonoSol claims in delivery film patent fight with BDSI

29-Nov-2011 - The USPTO has rejected MonoSol RX’s claims that production methods for a cancer pain patch developed by BioDelivery Sciences (BDSI) infringe on manufacturing techniques it uses to make its own...

China-focused USP committee to develop excipient standards

29-Nov-2011 - USP is creating a China-focused East Asia expert committee to develop quality standards for excipients.

Drug delivery research round-up

28-Nov-2011 - in-PharmaTechnologist presents its round-up of the latest drug delivery research developments in the pharmaceutical world, including tumour targeting peptides and lipid nanoparticle drug-delivery technology.

SOHM acquires Novatrend Medicament's product line in latest Indian forray

28-Nov-2011 - Generic drugs manufacturer SOHM is continuing its expansion into the Indian market with the acquisition of Novatrend Medicament’s product line.

FDA anti-adulteration efforts hindered by industry; GAO

28-Nov-2011 - Industry reluctance to share information on economic adulteration is hindering FDA efforts to tackle tainted ingredients, a GAO report found.

EC seeks industry feedback to shape serialisation policy

24-Nov-2011 - The EC is seeking industry comments before implementing the serialisation aspect of the falsified medicines directive.

Biocon close to finalising partnership for development of oral insulin

24-Nov-2011 - Biocon is close to signing an agreement with a partner willing to inject cash into its experimental insulin pill, said its MD.

News from Genesis, Acino and Pharmalink AB – People on the move

24-Nov-2011 - in-PharmaTechnologist presents its weekly line-up of the latest appointments in the pharmaceutical industry, including news from Genesis, Acino and Pharmalink AB.

News in brief

Pfizer gains 1st ISO 50001 energy accreditation at Ireland plant

24-Nov-2011 - A Pfizer Ireland plant has become the first in its network to achieve ISO accreditation for cutting CO2 emissions and energy use.

pSivida signs tech evaluation agreement for injectable implant

23-Nov-2011 - pSivida has inked a technology evaluation agreement with an unnamed global pharma over its Durasert drug delivery technology.

GSK urges FDA to consider absorption of nanomaterials in new guidance

23-Nov-2011 - GlaxoSmithKline (GSK) has urged the US FDA consider the absorption of nanomaterials in the gastrointestinal (GI) tract within its proposal for new regulations on nanotechnology.

EMA recalling oncology drugs manufactured by Ben Venue

23-Nov-2011 - The EMA is recalling cancer drugs manufactured by CMO Ben Venue Laboratories after inspectors found quality shortcomings.

News in brief

Shire submits regulatory filings for Massachusetts Vpriv plant

23-Nov-2011 - Shire has submitted EMA and FDA regulatory filings to add ‘substantial manufacturing capacity’ for Vpriv (velaglucerase alfa).

FDA sends Mylan Puerto Rico plant a GMP warning letter

23-Nov-2011 - The US FDA has sent Mylan a warning letter after inspectors found GMP testing failings at its Puerto Rico facility.

Schott strikes deal with Xinkang for joint venture in China

22-Nov-2011 - German technology giant Schott has signed an agreement with a Chinese firm to provide the fast-growing pharmaceutical market with a range of high-end glass packaging products.

FDA nanomaterial draft guidance means pointless extra regulation, say experts

22-Nov-2011 - FDA draft guidance defines nanoparticles too broadly and could result in APIs being categorised as nanomaterials, industry said.

News in brief

Biocon introduces insulin pen to Indian market

22-Nov-2011 - Biocon has begun selling a reusable insulin pen, based on Haselmeier technology, to patients in India.

Novavax leasing cGMP plant to meet expected vaccine demand

22-Nov-2011 - Novavax is leasing a cGMP plant in Maryland under ‘very favourable terms’ to meet anticipated demand for its VLP vaccines.

Gold nanoparticles can cut blood supply to tumours, say researchers

21-Nov-2011 - Gold nanoparticles can target endothelial cells to cut the supply of oxygen to most types of tumour, according to a new study.

Shortages to worsen after Ben Venue suspends manufacture

21-Nov-2011 - Ben Venue Laboratories has voluntarily suspended manufacture at the Ohio plant linked to drug shortages.

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...